Fatty Liver News and Research

Latest Fatty Liver News and Research

Researchers show the connection between NAFLD and diabetes risk in children

Nonalcoholic fatty liver disease (NAFLD) is the most common pediatric liver disease, affecting 5 to 8 million children in the United States. In NAFLD, the cells of the liver store large fat droplets, which can affect the function of the liver.

13 Jun 2022

Study: Avoiding high fructose consumption can help prevent the development of NAFLD

High fructose consumption should be avoided to prevent the development of non-alcoholic fatty liver disease (NAFLD), according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

13 Jun 2022

Etiologies of liver cancer are changing and the prognosis is mixed, study says

The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol and non-alcoholic steatohepatitis (NASH), a condition in which fat builds up in the liver, resulting in chronic inflammation and damage.

7 Jun 2022

Weight loss with bariatric surgery associated with lower risk of cancer and cancer-related mortality

A Cleveland Clinic study shows that among adults with obesity, weight loss achieved with bariatric surgery was associated with a 32% lower risk of developing cancer and a 48% lower risk of cancer-related death compared with adults who did not have the surgery.

3 Jun 2022

Benefits and limitations of non-invasive tests for diagnosing non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent chronic liver disorders worldwide and can sometimes lead to severe conditions like cirrhosis and hepatocellular carcinoma.

2 Jun 2022

NTU scientists discover why NAFLD patients are at higher risk of cardiovascular disease

Patients with non-alcoholic fatty liver disease (NAFLD) are at higher risk of cardiovascular disease, because NAFLD prompts the over-production of a class of proteins that cause inflammation and damage to their blood vessels.

25 May 2022

Study demonstrates how the transcription factor C/EBPβ can positively influence fat storage

The chronic nutritional and metabolic disease of obesity is characterized by an excessive increase in body fat and its accumulation in tissues.

20 May 2022

Lean people with NAFLD more likely to have cardiovascular disease than those who are overweight

Those with a normal body mass index (BMI) with non-alcoholic fatty liver disease (NAFLD) are more likely to have cardiovascular disease than those who are overweight or living with obesity, according to research selected for presentation at Digestive Disease Week 2022.

13 May 2022

Perceived stigmatization is common among patients with NAFLD, study finds

About seven out of ten patients (69%) who suffer from non-alcoholic fatty liver disease (NAFLD) perceive some stigmatization in their daily life, according to a study led by a team of the University of Barcelona, the Liver and Digestive Diseases Networking Biomedical Research Centre, the Hospital Clínic de Barcelona and the August Pi i Sunyer Biomedical Research Institute.

12 May 2022

Exercise can have a beneficial effect on factors contributing to NAFLD, study shows

Exercise supports the treatment of non-alcoholic fatty liver disease by impacting on several metabolic pathways in the body, a new study from the University of Eastern Finland shows.

3 May 2022

Novel therapy using nitric oxide may be an efficient and safe way to treat multiple metabolic diseases

A novel therapy developed at the University of Alabama at Birmingham ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet.

29 Apr 2022

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

First product within new ‘in-a-box’ range, which harnesses next-generation, human-relevant Liver-on-a-Chip technology to improve the accuracy and efficiency of NASH drug discovery.

From CN-Bio 26 Apr 2022

Researchers uncover a new protective mechanism against non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD), commonly known as fatty liver disease, is a prevalent disease frequently seen in obese people. Having high fat content in the liver is detrimental as it is strongly associated with severe health problems like diabetes, high blood pressure, and liver cancer.

20 Apr 2022

About one in four adults has a liver condition that is a risk factor for heart disease

It is estimated that about one in four adults worldwide has a liver condition that is a risk factor for heart disease, according to a new American Heart Association scientific statement published today in the Association's peer-reviewed journal Arteriosclerosis, Thrombosis, and Vascular Biology.

14 Apr 2022

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

A hormone that triggers puberty and controls fertility in humans might be developed as a treatment for non-alcoholic fatty liver disease, according to new Rutgers research.

7 Apr 2022

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Results from a preclinical study add new evidence that a multi-mineral dietary supplement known as Aquamin could be a simple and effective way to reduce the long-term health consequences of non-alcoholic fatty liver disease.

3 Apr 2022

Exploring the vital connection between gut microbes, physical activity, and health

Our bowels accommodate billions of active microbes that affect the health, a fact that is arousing increasing interest also among athletes.

26 Mar 2022

Study: Liver disease negatively impacted by lifestyle changes during the pandemic

Liver disease negatively impacted by lifestyle changes during the first year of the pandemic, according to a new study in the journal Liver International.

25 Mar 2022

Siemens Healthineers launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive prognostic tool.

From Siemens Healthineers Laboratory Diagnostics 17 Mar 2022

Targeting regulation of subcellular architecture may hold opportunities to treat metabolic diseases

Cells use their molecular architecture to regulate their metabolic functions, and repairing diseased cells' architecture to a healthier state can also repair metabolism, according to a study led by Harvard T.H. Chan School of Public Health researchers.

10 Mar 2022

Fatty Liver News and Research

Latest Fatty Liver News and Research

Researchers show the connection between NAFLD and diabetes risk in children

Study: Avoiding high fructose consumption can help prevent the development of NAFLD

Etiologies of liver cancer are changing and the prognosis is mixed, study says

Weight loss with bariatric surgery associated with lower risk of cancer and cancer-related mortality

Benefits and limitations of non-invasive tests for diagnosing non-alcoholic fatty liver disease

NTU scientists discover why NAFLD patients are at higher risk of cardiovascular disease

Study demonstrates how the transcription factor C/EBPβ can positively influence fat storage

Lean people with NAFLD more likely to have cardiovascular disease than those who are overweight

Perceived stigmatization is common among patients with NAFLD, study finds

Exercise can have a beneficial effect on factors contributing to NAFLD, study shows

Novel therapy using nitric oxide may be an efficient and safe way to treat multiple metabolic diseases

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

Researchers uncover a new protective mechanism against non-alcoholic fatty liver disease

About one in four adults has a liver condition that is a risk factor for heart disease

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Exploring the vital connection between gut microbes, physical activity, and health

Study: Liver disease negatively impacted by lifestyle changes during the pandemic

Siemens Healthineers launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

Targeting regulation of subcellular architecture may hold opportunities to treat metabolic diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Fatty Liver News and Research

Latest Fatty Liver News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in